THC Farmaceuticals, Inc. (CBDG)
USD 0.01
(8.0%)
USD 0.01
(8.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.74 Million USD | -1.08% |
| 2022 | 2.77 Million USD | -0.7% |
| 2021 | 2.79 Million USD | 20.18% |
| 2020 | 2.32 Million USD | -8.14% |
| 2019 | 2.53 Million USD | -8.07% |
| 2018 | 2.75 Million USD | 57.22% |
| 2017 | 1.75 Million USD | -0.03% |
| 2016 | 1.75 Million USD | 0.0% |
| 2014 | 48.15 USD | -1.09% |
| 2013 | 48.68 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 Q3 | 2.78 Million USD | -0.1% |
| 2022 Q1 | 2.78 Million USD | 0.0% |
| 2022 Q2 | 2.78 Million USD | -0.08% |
| 2021 FY | 2.79 Million USD | 20.18% |
| 2020 FY | 2.32 Million USD | -8.14% |
| 2020 Q1 | 1.67 Million USD | 0.0% |
| 2019 FY | 2.53 Million USD | -8.07% |
| 2019 Q2 | 3.37 Million USD | 0.0% |
| 2019 Q3 | 2.53 Million USD | -25.02% |
| 2018 FY | 2.75 Million USD | 57.22% |
| 2017 FY | 1.75 Million USD | -0.03% |
| 2016 FY | 1.75 Million USD | 0.0% |
| 2015 Q3 | 1715.14 USD | 0.69% |
| 2015 Q2 | 1703.37 USD | 3202.76% |
| 2015 Q1 | 51.57 USD | 7.11% |
| 2014 Q1 | 48.38 USD | -0.61% |
| 2014 Q4 | 48.15 USD | -2.19% |
| 2014 FY | 48.15 USD | -1.09% |
| 2014 Q3 | 49.23 USD | 1.26% |
| 2014 Q2 | 48.62 USD | 0.48% |
| 2013 FY | 48.68 USD | 0.0% |
| 2013 Q2 | 49.75 USD | 0.0% |
| 2013 Q4 | 48.68 USD | -0.97% |
| 2013 Q3 | 49.16 USD | -1.2% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -118788.961% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -40.249% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 73.978% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -397.416% |
| Rebus Holdings, Inc. | 5000.00 USD | -54826.7% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 97.891% |
| Qrons Inc. | 420.00 USD | -653789.286% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -256.369% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 90.172% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -471.49% |
| Skye Bioscience, Inc. | 11.94 Million USD | 77.0% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 92.93% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 61.961% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -3496.845% |
| SQZ Biotechnologies Company | 107.18 Million USD | 97.438% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -91.779% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -3695.115% |
| Mesoblast Limited | 667.9 Million USD | 99.589% |
| Marizyme, Inc. | 22.01 Million USD | 87.525% |
| Genus plc | 1.02 Billion USD | 99.733% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -102.181% |
| Pharming Group N.V. | 462.85 Million USD | 99.407% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 17.105% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -450.325% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -338.012% |
| ContraFect Corporation | 20.67 Million USD | 86.719% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -603.528% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -618.603% |
| IMV Inc. | 31.33 Million USD | 91.235% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 33.76% |
| MultiCell Technologies, Inc. | 126.22 USD | -2175731.881% |
| ONE Bio Corp. | 70.08 Million USD | 96.081% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -192.26% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 97.863% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -536.147% |
| Q BioMed Inc. | 3.51 Million USD | 21.88% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 92.193% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -951.12% |
| Biomind Labs Inc. | 73.81 Thousand USD | -3620.363% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.385% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -89.554% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 90.85% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -299.475% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -5.499% |
| GB Sciences, Inc. | 103.44 Thousand USD | -2554.952% |
| Alpha Cognition Inc. | 2.45 Million USD | -11.996% |
| HST Global, Inc. | 1526.00 USD | -179869.528% |
| CSL Limited | 38.02 Billion USD | 99.993% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -177.978% |
| Halberd Corporation | 10.13 Thousand USD | -27008.232% |
| Enzolytics Inc. | 361.7 Million USD | 99.241% |
| Agentix Corp. | 261.39 Thousand USD | -950.658% |
| Resverlogix Corp. | 8.11 Million USD | 66.157% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -46.247% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.94% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 94.243% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -329.346% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -11955.375% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 69.312% |
| AVAX Technologies, Inc. | 7.37 Million USD | 62.772% |
| Zenith Capital Corp. | 7410.00 USD | -36962.551% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.919% |
| Ember Therapeutics, Inc. | 184.00 USD | -1492473.37% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -753.413% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -950.77% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -195.954% |
| Kadimastem Ltd | 2.3 Million USD | -19.194% |
| Helix BioMedix, Inc. | 3.02 Million USD | 9.215% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 94.789% |
| BioStem Technologies, Inc. | 14.56 Million USD | 81.138% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -4710.199% |
| LadRx Corporation | 2.3 Million USD | -18.998% |
| Cell Source, Inc. | 195.17 Thousand USD | -1307.143% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -676.641% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -676.641% |
| NovAccess Global Inc. | 62.24 Thousand USD | -4311.925% |
| Affymax, Inc. | 7.44 Million USD | 63.102% |
| Itoco Inc. | 1.4 Million USD | -96.157% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -2771.024% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -2490.882% |
| Mobile Lads Corp. | 52.00 USD | -5281313.462% |
| CytoDyn Inc. | 11.13 Million USD | 75.338% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -1820.89% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -15259.815% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -612.462% |
| SYBLEU INC | 330.46 Thousand USD | -731.044% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -570.783% |
| International Stem Cell Corporation | 5.39 Million USD | 49.048% |
| Bioxytran, Inc. | 137.63 Thousand USD | -1895.332% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 81.693% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 83.435% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -3376.373% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -217.614% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 63.465% |
| Neutra Corp. | 2851.00 USD | -96228.832% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 91.525% |
| PureTech Health plc | 693.97 Million USD | 99.604% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 65.973% |
| IXICO plc | 15.84 Million USD | 82.666% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 66.84% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 97.342% |
| CSL Limited | 38.02 Billion USD | 99.993% |
| Cellectis S.A. | 333.99 Million USD | 99.178% |